FB2026_02 , released June 18, 2026
Reference Report
Open Close
Reference
Citation
Mohanty, P.K., Kumari, N., Kerry, R.G., Ray, A., Bhol, N.K., Panigrahi, B., Majhi, S., Rath, P.K., Nayak, S., Badamali, S.K. (2025). Ecofriendly Fabrication and Hierarchical Exploration of Cytocompatible Lignin Nanoparticles for Biomedical Applications.  ACS Appl Bio Mater 8(11): 9709--9729.
FlyBase ID
FBrf0263966
Publication Type
Research paper
Abstract
Lignin, the most abundant renewable aromatic biopolymer, offers significant potential for bionanomaterial innovation in biomedical applications. This study presents a facile method for isolating soda lignin from waste coconut shells, followed by its standard characterizations and the design of lignin nanoparticles (LNPs) using a greener approach. A hierarchical exploration of the LNPs was performed, encompassing structural and molecular characterizations, in vitro enzymatic as well as cellular studies, in vivo assays using Drosophila melanogaster (D. melanogaster) as a model organism, in silico molecular docking, and molecular dynamics simulations. The resulting LNPs exhibited well-defined nanostructures with an average hydrodynamic diameter (DH) of 86.59 ± 2.6 nm (DLS measurement), a spherical morphology (∼55 nm from FESEM measurement), hollow nanoarchitecture (pore diameter ∼60 nm), high colloidal stability (zeta potential: -41.1 ± 1.1 mV), and a broad emission spectrum (270-600 nm). Additionally, advanced techniques such as micro-FTIR, micro-Raman, XRD (X-ray diffraction), and TGA-DSC studies further validated the successful LNP synthesis and structural integrity. In vitro and in vivo bioactivity studies with D. melanogaster demonstrated that LNPs significantly outperform bulk lignins in terms of antidiabetic, antioxidant, and cytotoxicity properties. In silico molecular docking and molecular dynamics simulation studies supported these findings. The in vitro antidiabetic assay showed inhibition activities of 53.27 ± 1.3% (α-amylase) and 66.23 ± 1.5% (α-glucosidase) at 10 μg/mL, similar to the standard inhibitor acarbose. The LNPs exhibited strong antioxidant activity (56.6 ± 0.6% at 10 μg/mL), comparable to allopurinol (77.33 ± 1.4%). Along with this, LNPs displayed enhanced catalase activity (1.2-fold), reduced ROS levels (0.3-fold at 1 μg/mL), maintained glutathione levels, and did not increase H2O2 levels that might induce oxidative stress. MTT assays confirmed good biocompatibility in HCT cells, while in vivo acute toxicity studies with D. melanogaster indicated higher survivorship than bulk lignins.
PubMed ID
PubMed Central ID
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    ACS Appl Bio Mater
    Title
    ACS applied bio materials
    ISBN/ISSN
    2576-6422
    Data From Reference
    Chemicals (1)
    Human Disease Models (1)